CCR2 expression on these cells is known to mediate bone marrow egress and recruitment into inflamed tissues in response to CCL2 (80) which seems to be elevated in serum and bronchoalveolar fluid (BALF) samples obtained from COVID-19 patients (60, 62, 81). This evidence concerns the gene CCL2 and COVID-19.